γδT cells produce the majority of IL-17A in the acute phase (3 days following stroke), while the majority of IL-17A in the chronic phase (28 days later) is produced by astrocytes, and have different roles in recovery at different temporal stages [206]. This evidence concerns the gene IL17A and stroke disorder.